NCT03454529 2023-08-01
The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
Clinical Trials
13 trialsNCT01156545 2022-04-06
BIBW 2992 Plus Simvastatin vs. BIBW 2992 in Previously Treated Patients With Advanced Non-adenocarcinomatous NSCLC
National Cancer Center, Korea
Phase 2 Completed
NCT04418089 2020-06-05
Simvastatin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response and Tumor-Free Margin in Locally Advanced Breast Cancer
Indonesia University
Phase 2 Completed
NCT00334542 2019-04-03
Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT02026583 2018-01-17
A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer Patients
Samsung Medical Center
Phase 2 Completed
NCT00452244 2017-08-25
Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC)
National Cancer Center, Korea
Phase 2 Completed
NCT00944463 2017-02-17
Trial of Simvastatin and Gemcitabine in Pancreatic Cancer Patients
Samsung Medical Center
Phase 2 Completed
NCT02104193 2016-02-17
Simvastatin Effect on Radiation Therapy of Brain Metastases
Ain Shams University
Phase 2 Completed
NCT01500577 2014-06-18
A Prevention Trial in Subjects at High Risk for Breast Cancer
European Institute of Oncology
Phase 2 Completed
NCT00354640 2013-06-24
Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00452634 2013-06-19
Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC)
National Cancer Center, Korea
Phase 2 Completed
NCT00313859 2012-02-02
Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC
Samsung Medical Center
Phase 2 Completed
NCT00399867 2006-12-20
Simvastatin as Inhibitor of Cell Adhesion Mediated Drug Resistance in Patients With Refractory Multiple Myeloma.
Ludwig-Maximilians - University of Munich
Phase 2 Completed